Omega Healthcare Investors
Omega Healthcare Investors
OHI
NYSE
39.54
USD
-0.50%
About
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs).
Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 891 healthcare facilities, located in 42 states and the United Kingdom that are operated by 74 third-party operators..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 1.5M |
| Three Month Average Volume | 34.2M |
| High Low | |
| Fifty-Two Week High | 39.688 USD |
| Fifty-Two Week Low | 27.5294 USD |
| Fifty-Two Week High Date | 30 Aug 2024 |
| Fifty-Two Week Low Date | 05 Feb 2024 |
| Price and Volume | |
| Current Price | 39.54 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | -2.18% |
| Thirteen Week Relative Price Change | 14.27% |
| Twenty-Six Week Relative Price Change | 16.00% |
| Fifty-Two Week Relative Price Change | -0.83% |
| Year-to-Date Relative Price Change | 8.90% |
| Price Change | |
| One Day Price Change | 0.33% |
| Thirteen Week Price Change | 22.30% |
| Twenty-Six Week Price Change | 27.55% |
| Five Day Price Change | 1.83% |
| Fifty-Two Week Price Change | 24.26% |
| Year-to-Date Price Change | 28.96% |
| Month-to-Date Price Change | 8.63% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 14.57336 USD |
| Book Value Per Share (Most Recent Quarter) | 14.60851 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 11.94545 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 12.07158 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | 3.30378 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 3.79212 USD |
| Revenue Per Share (Trailing Twelve Months) | 3.7976 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | 2.68 USD |
| Dividend Per Share (Trailing Twelve Months) | 2.135 USD |
| Dividend Per Share (5 Year) | 2.4099 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | 0.99523 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | 1.30902 USD |
| Normalized (Last Fiscal Year) | 1.06577 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | 1.00701 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | 1.32417 USD |
| Including Extraordinary Items (Last Fiscal Year) | 0.99523 USD |
| Including Extraordinary Items (Trailing Twelve Months) | 1.30902 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 1.80531 USD |
| Cash Per Share (Most Recent Quarter) | 0.13854 USD |
| Cash Flow Per Share (Last Fiscal Year) | 2.27214 USD |
| Cash Flow Per Share (Trailing Twelve Months) | 2.50362 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -1.14875 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -40 |
| Cash Flow Revenue (Trailing Twelve Months) | -30 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | 35.77% |
| Pretax Margin (Last Fiscal Year) | 26.92% |
| Pretax Margin (5 Year) | 34.25% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 98.42% |
| Gross Margin (Trailing Twelve Months) | 98.50% |
| Gross Margin (5 Year) | 98.51% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | 16.39% |
| Operating Margin (Trailing Twelve Months) | 26.51% |
| Operating Margin (5 Year) | 19.53% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | 26.26% |
| Net Profit Margin (Trailing Twelve Months) | 34.69% |
| Net Profit Margin (5 Year) | 33.78% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -3.06% |
| Tangible Book Value (5 Year) | 0.93% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 1.02% |
| Revenue Growth (3 Year) | 1.50% |
| Revenue Change (Trailing Twelve Months) | 14.63% |
| Revenue Per Share Growth | -2.04% |
| Revenue Growth (5 Year) | 2.10% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 4.65% |
| Total Debt (5 Year) | 2.22% |
| Dividends | |
| Dividend Growth (3 Year) | 0.00% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 79.44% |
| EPS Change (Trailing Twelve Months) | 29.60% |
| EPS Growth (3 Year) | -5.81% |
| EPS Growth (5 Year) | 13.67% |
| EBITDA | |
| EBITDA (5 Year) | -0.07% |
| EBITDA (5 Year Interim) | 0.67% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -4.63% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 3 |
| Price to Tangible Book (Most Recent Quarter) | 3 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | 4.6B |
| Net Debt (Last Fiscal Year) | 4.6B |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 11 |
| Price to Sales (Trailing Twelve Months) | 10 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | 30 |
| PE Normalized (Last Fiscal Year) | 37 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | 26 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 55 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 15 |
| PE Including Extraordinary Items (Trailing Twelve Months) | 30 |
| Dividends | |
| Dividend Yield (5 Year) | 7.22% |
| Dividend Yield | 6.78% |
| Current Dividend Yield | 5.40% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 3 |
| Price to Book (Most Recent Quarter) | 3 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 142 |
| Long Term Debt to Equity (Most Recent Quarter) | 126 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | 265.95% |
| Payout Ratio (Trailing Twelve Months) | 201.46% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | -100,000 |
| Quick Ratio (Most Recent Quarter) | -100,000 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | -100,000 |
| Current Ratio (Most Recent Quarter) | -100,000 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -333,079,000 |
| Free Cash Flow (Trailing Twelve Months) | -295,656,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | 2 |
| Net Interest Coverage (Trailing Twelve Months) | 2 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 142 |
| Total Debt to Equity (Most Recent Quarter) | 126 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | 2.69% |
| Return on Assets (Trailing Twelve Months) | 3.72% |
| Return on Assets (5 Year) | 3.37% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | 6.74% |
| Return on Equity (Trailing Twelve Months) | 8.93% |
| Return on Equity (5 Year) | 8.35% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | 2.84% |
| Return on Investment (Trailing Twelve Months) | 3.92% |
| Return on Investment (5 Year) | 3.55% |